Voyager Therapeutics Inc (VYGR) Lifted to “Hold” at Zacks Investment Research

Voyager Therapeutics Inc (NASDAQ:VYGR) was upgraded by Zacks Investment Research from a “sell” rating to ... programs comprise VY-SOD101 for a monogenic form of amyotrophic lateral sclerosis, VY-FXN01 for Friedreich ataxia and VY-HTT01 for Huntington ...